Nina Tatarova
Nina Tatarova has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Vitaliy Fyodorovich Bezhenar
Federal State Budgetary Educational Institution of Higher Education “First St. Petersburg State Medical University named after Academician I.P. Pavlova» of the Ministry of Health of Russia
6 shared publications - Biuzand V. Arakelyan
Pavlov University
3 shared publications - A. Yu. Ralnikova
Pavlov University
2 shared publications M.S. Ayrapetyan
2 shared publicationsSaint Petersburg Iclinic Sz
2 shared publicationsV.A. Linde
2 shared publications
Latest Publications
- Open Access
- 16 September 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 32 (2) , 18-25
Chronic endometritis and fertility
This review was based on the databases https://cyberleninka.ru/, PubMed, MedArt, and CSML. In recent decades, chronic endometritis has received increasing attention as a potential factor in unexplained infertility or recurrent pregnancy loss, especially in cases of unsuccessful in vitro fertilization programs or repeated early miscarriages. At the same time, the nosological entity of «chronic endometritis» remains insufficiently defined.From a pathogenetic perspective, two variants of chronic endometritis development are identified: an infectious-inflammatory process and an autoimmune pathology, in which the initial triggering factor that started the process is leveled. Immunologic changes associated with processes that affect the outcome of implantation, determining fertility impairment, are nonspecific and cannot be considered as diagnostic criteria for chronic endometritis. The exception is, with reservations, infiltration of CD138 (+) plasmacytes by endometrial stroma. The endometrial receptor disorder detected in chronic endometritis appears to be a nonspecific result of a large number of heterogeneous pathologic conditions.If the infectious-inflammatory pathway of chronic endometritis development is proven, etiotropic therapy aimed at elimination of the infectious agent is justified. In other cases, it is necessary to identify the causes and/or maintenance of secondary autoimmune process.The objective of the review was to facilitate the physicians’ search for the most effective ways to overcome infertility and pregnancy failure associated with chronic endometritis.
- 16 September 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 32 (2) , 18-25
Open AccessChronic endometritis and fertility
This review was based on the databases https://cyberleninka.ru/, PubMed, MedArt, and CSML. In recent decades, chronic endometritis has received increasing attention as a potential factor in unexplained infertility or recurrent pregnancy loss, especially in cases of unsuccessful in vitro fertilization programs or repeated early miscarriages. At the same time, the nosological entity of «chronic endometritis» remains insufficiently defined.From a pathogenetic perspective, two variants of chronic endometritis development are identified: an infectious-inflammatory process and an autoimmune pathology, in which the initial triggering factor that started the process is leveled. Immunologic changes associated with processes that affect the outcome of implantation, determining fertility impairment, are nonspecific and cannot be considered as diagnostic criteria for chronic endometritis. The exception is, with reservations, infiltration of CD138 (+) plasmacytes by endometrial stroma. The endometrial receptor disorder detected in chronic endometritis appears to be a nonspecific result of a large number of heterogeneous pathologic conditions.If the infectious-inflammatory pathway of chronic endometritis development is proven, etiotropic therapy aimed at elimination of the infectious agent is justified. In other cases, it is necessary to identify the causes and/or maintenance of secondary autoimmune process.The objective of the review was to facilitate the physicians’ search for the most effective ways to overcome infertility and pregnancy failure associated with chronic endometritis.
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 13 (3)
Complex alternative (phytoestrogens + hyaluronic acid) therapy of genitourinary syndrome of menopause
Комплексная альтернативная (фитоэстрогены + гиалуроновая кислота) терапия генитоуринарного менопаузального синдрома
- 1 January 2025
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 13 (3)
Open AccessComplex alternative (phytoestrogens + hyaluronic acid) therapy of genitourinary syndrome of menopause
Комплексная альтернативная (фитоэстрогены + гиалуроновая кислота) терапия генитоуринарного менопаузального синдрома
- 29 March 2023
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 72 (1) , 119-121
To the 90th anniversary of Professor Leonid Andreyevich Susloparov
The article presents the life path of Doctor of Medical Sciences, Professor Susloparov Leonid Andreyevich, his scientific achievements, pedagogical and clinical work.
- 29 March 2023
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 72 (1) , 119-121
To the 90th anniversary of Professor Leonid Andreyevich Susloparov
The article presents the life path of Doctor of Medical Sciences, Professor Susloparov Leonid Andreyevich, his scientific achievements, pedagogical and clinical work.
- Open Access
- 9 September 2021
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 15 (4) , 360-370
Risk factors for perinatal loss - reality or fiction?
Aim: to identify factors predisposing to perinatal losses, assessment of which is available at the first (only) visit of pregnant woman in antenatal clinic.Materials and Methods. A retrospective analysis of the medical records of 964 women who performed delivery in 2009-2019 in 15 obstetric facilities was carried out. The patients were divided into 2 groups: the main group included 457 women with perinatal losses (stillbirth - 328 children, and 129 children with early neonatal death); the control group consisted of 507 women, whose children survived 7 days during postnatal period. We analyzed parameters routinely determined by an obstetrician-gynecologist at the first visit of woman during within ongoing pregnancy (regardless of gestation age), namely, social status, anamnesis, data of initial examination.Results. The following significant differences were revealed in pregnant women from the main group: a younger age of pregnancy; no registered marriage and permanent job as well as primary and secondary education; smoking, alcohol and drug use; concurrent diabetes mellitus, hypertensive disorders, blood contact infections, obesity; older menarche age and younger sexual debut age; medical history contains infectious genital pathology, more often pregnancies and childbirths, two or more abortions before repeated childbirth, premature births.Conclusion. Thus, the anamnestic indicators noted above can be used to create prognostic statistical systems and models to determine high risk of perinatal losses of any nature.
- 9 September 2021
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 15 (4) , 360-370
Open AccessRisk factors for perinatal loss - reality or fiction?
Aim: to identify factors predisposing to perinatal losses, assessment of which is available at the first (only) visit of pregnant woman in antenatal clinic.Materials and Methods. A retrospective analysis of the medical records of 964 women who performed delivery in 2009-2019 in 15 obstetric facilities was carried out. The patients were divided into 2 groups: the main group included 457 women with perinatal losses (stillbirth - 328 children, and 129 children with early neonatal death); the control group consisted of 507 women, whose children survived 7 days during postnatal period. We analyzed parameters routinely determined by an obstetrician-gynecologist at the first visit of woman during within ongoing pregnancy (regardless of gestation age), namely, social status, anamnesis, data of initial examination.Results. The following significant differences were revealed in pregnant women from the main group: a younger age of pregnancy; no registered marriage and permanent job as well as primary and secondary education; smoking, alcohol and drug use; concurrent diabetes mellitus, hypertensive disorders, blood contact infections, obesity; older menarche age and younger sexual debut age; medical history contains infectious genital pathology, more often pregnancies and childbirths, two or more abortions before repeated childbirth, premature births.Conclusion. Thus, the anamnestic indicators noted above can be used to create prognostic statistical systems and models to determine high risk of perinatal losses of any nature.
- Open Access
- 3 January 2021
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 179 (5) , 81-86
Malignant tumors of the digestive system during pregnancy: problems of timely diagnosis
Currently, the age of primiparous women is increasing, but the risk of cancer, which is sometimes found during gestation, is also increasing. This article discusses the problems of diagnosis and treatment of cancer during pregnancy, which occurs under the guise of gestational complications. Two cases of malignant neoplasms first discovered during pregnancy are described. The first observation illustrates cholangiocarcinoma in a 37-year-old multiparous, and the second is a case of colorectal cancer in a 40-year-old primiparous. The timely identification of such women is an important challenge of the outpatient, which in the future can help maintain the quality of life of the mother and child.
- 3 January 2021
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 179 (5) , 81-86
Open AccessMalignant tumors of the digestive system during pregnancy: problems of timely diagnosis
Currently, the age of primiparous women is increasing, but the risk of cancer, which is sometimes found during gestation, is also increasing. This article discusses the problems of diagnosis and treatment of cancer during pregnancy, which occurs under the guise of gestational complications. Two cases of malignant neoplasms first discovered during pregnancy are described. The first observation illustrates cholangiocarcinoma in a 37-year-old multiparous, and the second is a case of colorectal cancer in a 40-year-old primiparous. The timely identification of such women is an important challenge of the outpatient, which in the future can help maintain the quality of life of the mother and child.
- 1 January 2021
- Published by Dynasty Publishing House in Voprosy Ginekologii, Akušerstva i Perinatologii
- Vol. 20 (2)
Non-hormonal treatment for genitourinary syndrome of menopause
The genitourinary syndrome of menopause (GSM) is due to the development of atrophic and dystrophic processes in estrogendependent tissues and structures of the lower third of urinary tract in different periods of aging of the reproductive system. Nonhormonal treatment for GSM is considered as a first-line treatment and includes the use of gels, creams and suppositories that contribute to the restoration of hydrolipid balance, stimulating the collagen production that have an anti-inflammatory, antiseptic, regenerating effect, as well as increasing mucosal resistance and reducing the risk of adhesion of conditionally pathogenic infection. Objective. To evaluate the effectiveness, safety and acceptability of the vaginal cream for intimate hygiene EstrogialTM Plus in women with symptoms of vulvovaginal atrophy (VVA) and GSM. Patients and methods. 24 women aged 43 to 58 were examined. The inclusion criteria were the symptoms of GSM and VVA, the vaginal health index – no more than 20 points. During the course of the study, four visits were carried out, including standard observational procedures, filling the Quality of Life Questionnaire, the administration of treatment. The application of the cream Estrogial™ Plus in doses was prescribed 1 time per day on the vulvar vestibule for 30 days. The effectiveness of therapy was evaluated, all patients continued therapy for up to 60 days. According to the modified questionnaire for general clinical assessment, the state «very much improved» was revealed in 83.3% of patients with a severe form of GSM and VVA and in 66.7% with moderate VVA, «much improved» – in the rest. After treatment, 52% of patients had no symptoms of VVA, and 48% had symptoms in a mild form. Filling the Menopause-Specific Quality of Life Questionnaire (MENQOL), all 24 patients reported positive effects in the form of increased libido and reduced vaginal dryness during sexual intercourses. The study presents clinical cases of cured patients with GSM and VVA. Conclusion. The data obtained during the study make it possible to conclude that the intravaginal administration of the cream EstrogialTM Plus in doses is effective for the treatment of GSM and VVA. The proven therapeutic effects and safety of the use of local non-hormonal treatment enhance the prospects for providing treatment and preventive care for women during the menopausal transition and menopause. Key words: vulvovaginal atrophy, genitourinary syndrome of menopause, non-hormonal treatment, Estrogial™ Plus
- 1 January 2021
- Published by Dynasty Publishing House in Voprosy Ginekologii, Akušerstva i Perinatologii
- Vol. 20 (2)
Non-hormonal treatment for genitourinary syndrome of menopause
The genitourinary syndrome of menopause (GSM) is due to the development of atrophic and dystrophic processes in estrogendependent tissues and structures of the lower third of urinary tract in different periods of aging of the reproductive system. Nonhormonal treatment for GSM is considered as a first-line treatment and includes the use of gels, creams and suppositories that contribute to the restoration of hydrolipid balance, stimulating the collagen production that have an anti-inflammatory, antiseptic, regenerating effect, as well as increasing mucosal resistance and reducing the risk of adhesion of conditionally pathogenic infection. Objective. To evaluate the effectiveness, safety and acceptability of the vaginal cream for intimate hygiene EstrogialTM Plus in women with symptoms of vulvovaginal atrophy (VVA) and GSM. Patients and methods. 24 women aged 43 to 58 were examined. The inclusion criteria were the symptoms of GSM and VVA, the vaginal health index – no more than 20 points. During the course of the study, four visits were carried out, including standard observational procedures, filling the Quality of Life Questionnaire, the administration of treatment. The application of the cream Estrogial™ Plus in doses was prescribed 1 time per day on the vulvar vestibule for 30 days. The effectiveness of therapy was evaluated, all patients continued therapy for up to 60 days. According to the modified questionnaire for general clinical assessment, the state «very much improved» was revealed in 83.3% of patients with a severe form of GSM and VVA and in 66.7% with moderate VVA, «much improved» – in the rest. After treatment, 52% of patients had no symptoms of VVA, and 48% had symptoms in a mild form. Filling the Menopause-Specific Quality of Life Questionnaire (MENQOL), all 24 patients reported positive effects in the form of increased libido and reduced vaginal dryness during sexual intercourses. The study presents clinical cases of cured patients with GSM and VVA. Conclusion. The data obtained during the study make it possible to conclude that the intravaginal administration of the cream EstrogialTM Plus in doses is effective for the treatment of GSM and VVA. The proven therapeutic effects and safety of the use of local non-hormonal treatment enhance the prospects for providing treatment and preventive care for women during the menopausal transition and menopause. Key words: vulvovaginal atrophy, genitourinary syndrome of menopause, non-hormonal treatment, Estrogial™ Plus
- 26 November 2020
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 11-12,p. 19-27
Cholangiocarcinoma in pregnancy (clinical case)
The article discusses the problems of diagnosing biliary cancer during pregnancy, proceeding under the guise of complications associated with gestation. A clinical observation of late diagnosis of cholangiocarcinoma in a pregnant woman is presented.
- 26 November 2020
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 11-12,p. 19-27
Cholangiocarcinoma in pregnancy (clinical case)
The article discusses the problems of diagnosing biliary cancer during pregnancy, proceeding under the guise of complications associated with gestation. A clinical observation of late diagnosis of cholangiocarcinoma in a pregnant woman is presented.
- Open Access
- 23 November 2020
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 22 (5) , 87-90
Vitamin D deficiency and iron deficiency anemia in women in menopausal transition period. Clinical case
Vitamin D is a regulator of immune response, and plays a role in the development of cardiovascular diseases, insulin resistance and diabetes mellitus, obesity, autoimmune disorders, iron binding, anemia, respiratory viral and other diseases. In addition, vitamin D deficiency contributes to the chronicity of infections and an increased risk for number of oncological pathology. The developing immunosuppression in women with iron deficiency anemia in the menopausal transition period does not allow to fully compensate for iron deficiency with monotherapy if vitamin D deficiency is present. The drug of choice in this situation is micellized (water-soluble) vitamin D3(Aquadetrim).
- 23 November 2020
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 22 (5) , 87-90
Open AccessVitamin D deficiency and iron deficiency anemia in women in menopausal transition period. Clinical case
Vitamin D is a regulator of immune response, and plays a role in the development of cardiovascular diseases, insulin resistance and diabetes mellitus, obesity, autoimmune disorders, iron binding, anemia, respiratory viral and other diseases. In addition, vitamin D deficiency contributes to the chronicity of infections and an increased risk for number of oncological pathology. The developing immunosuppression in women with iron deficiency anemia in the menopausal transition period does not allow to fully compensate for iron deficiency with monotherapy if vitamin D deficiency is present. The drug of choice in this situation is micellized (water-soluble) vitamin D3(Aquadetrim).
- Open Access
- 28 September 2020
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 69 (4) , 101-106
Postoperative scar endometriosis (clinical observation)
A clinical observation of endometrioid infiltrate of a postoperative scar formed as a result of surgical delivery by cesarean section is presented in this article.
- 28 September 2020
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 69 (4) , 101-106
Open AccessPostoperative scar endometriosis (clinical observation)
A clinical observation of endometrioid infiltrate of a postoperative scar formed as a result of surgical delivery by cesarean section is presented in this article.
- 29 May 2020
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 5_2020
Tissue thermometric characteristics in the intervention area during electrosurgical vaginal hysterectomy
- 29 May 2020
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 5_2020
Tissue thermometric characteristics in the intervention area during electrosurgical vaginal hysterectomy